Characteristics and outcomes of middle east respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia

Journal of Intensive Care Medicine

Volumn 31, Issue 5, 2016, Pages 344-348

  Al Hameed, Fahad ^a,b   Wahla, Ali S ^a   Siddiqui, Shakeel ^a   Ghabashi, Alaa ^a,b   Al Shomrani, Majid ^a,b   Al Thaqafi, Abdulhakeem ^a,b   Tashkandi, Yasir ^a,b  

^a KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

intensive care; Middle East respiratory syndrome coronavirus; respiratory failure

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CORONAVIRUS INFECTION; COUGHING; CRITICALLY ILL PATIENT; DISEASE DURATION; FATALITY; FEMALE; FEVER; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LYMPHOCYTOPENIA; MALE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY RATE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; SAUDI ARABIA; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; CROSS INFECTION; EPIDEMIOLOGY; HOSPITALIZATION; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SAUDI ARABIA; TREATMENT OUTCOME;

EID: 84966539579     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066615579858     Document Type: Article

References (15)

1. Zaki AM, van BS, Bestebroer TM, Osterhaus AD, Fouchier RA,. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367 (19): 1814-1820.
2. Cotten M, Watson SJ, Kellam P, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet. 2013; 382 (9909): 1993-2002.
3. Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014; 370 (26): 2499-2505.
4. Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014; 160 (6): 389-397.
5. Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013; 495 (7440): 251-254.
6. Lamers D, Famulla S, Wronkowitz N, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes. 2011; 60 (7): 1917-1925.
7. Barnett A,. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int J Clin Pract. 2006; 60 (11): 1454-1470.
8. Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005; 41 (8): 1089-1096.
9. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348 (20): 1986-1994.
10. Leung TW, Wong KS, Hui AC, et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol. 2005; 62 (7): 1113-1117.
11. Al-Abdallat MM, Payne DC, Alqasrawi S, et al. Hospital-associated outbreak of middle east respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014; 59 (9): 1225-1233.
12. Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013; 381 (9885): 2265-2272.
13. Falzarano D, de Wit E, Rasmussen AL, et al. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013; 19 (10): 1313-1317.
14. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA,. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014; 20: 42-46.
15. Brun-Buisson C, Richard JC, Mercat A, Thiébaut AC, Brochard L, REVA-SRLF A/H1N1v 2009 Registry Group. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011; 183 (9): 1200-1206.